EUROPEAN COMMISSION  
DG Competition  
 
 
 
 Case M.9930 - LGP / TPG / 
WELLSKY  
 
 
 
 
Only the English text is available and authentic.  
 
 
 
REGULATION (E C) No 139/2004 
MERGER PROCEDURE  
 
 
 
Article 6(1)(b) NON -OPPOSITION  
Date: 15/09/2020 
 
 
 
 
 
 
 
 
In electronic form on the EUR-Lex website under document 
number 32020M9930 

 
 
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229- 91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu.  
  EUROPEAN COMMISSION  
Brussels,  15.09.2020  
C(2020)  6387 final  
PUBLIC VERSION 
To the notifying parties  
Subject : Case M. 9930 – LGP / TPG / WELLSKY  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No  139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 18 August  2020, the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which Leonard Green 
& Partner s, L.P. (“LGP”, USA)  and TPG Capital (“TPG”, USA ) acquire within the 
meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of  the 
whole of  WellSky Corporation (“WellSky” or the "Target", USA), currently solely 
controlled by TPG  by way of purchase of shares .3 
2. The business activities of the undertakings concerned are:  
− LGP : private equity investment firm,  primarily investing in companies providing 
services, including consumer, business, and healthcare services, as well as retail, 
distribution, and industrials , 
− TPG : private investment firm that manages a family of funds that invest in a 
variety of companies through acquisitions and corporate restructurings , 
− WellSky : provider of specialty healthcare software (Software as a Service, 
“SaaS”  and other software platforms), used in the management of clinical, 
financial and administrative work flows. In the EEA, WellSky only markets 
software solutions, which address medication management and chemotherapy 
management software.  
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union’  and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication  in the Official Journal of the European Union No C 2 80, 25.08.2020 , p. 21. 

2 3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation and of 
paragraph 5(a) of the Commission Notice on a simplified procedure for treatment of 
certain concentrations und er Council Regulation (EC) No  139/2004.4 
4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agreement . 
For the Commission 
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
                                                 
4  OJ C 366, 14.12.2013, p. 5.